PE Biosimilars
-
Anti-Human CD20 (Rituximab) - PE Biosimilar (IVMB0525)
system_update_altDatasheetsystem_update_altMSDS -
Anti-Human IL 12/23 (Briakinumab) - PE Biosimilar (IVMB0508)
system_update_altDatasheetsystem_update_altMSDS